Aphasix

Based in France, Aphasix SAS provides a digital platform dedicated to language rehabilitation for individuals with aphasia, delivering personalized training exercises for enhancing communication skills. Aphasix SAS, established in 2024, is a company located in Boulogne-Billancourt, France, focusing on developing a digital rehabilitation platform for those with aphasia. The company has completed 1 deal, with its most recent deal on November 24, 2025. Aphasix successfully raised EUR 1 million in Seed funding, which brings the total amount raised to EUR 1 million.

Aphasix offers a digital platform designed specifically for individuals with aphasia, focusing on language rehabilitation. The platform provides personalized training exercises that adapt to the user's performance and goals, enabling users to practice speech and language skills at their own pace, 24/7. Key features include daily challenges, progress tracking, and a community space for users to connect and share experiences. The solution is tailored to various aspects of aphasia, including difficulties in verbal expression, written communication, and comprehension.

Aphasix primarily serves patients recovering from strokes and their families in markets across France and potentially other European regions where access to rehabilitation services may be limited. Aphasix generates revenue through subscription-based models, offering two primary pricing plans: an Ambassador plan at EUR 19 per month and a Standard plan at EUR 39 per month. Both plans include a 15-day free trial, allowing users to access all features without immediate commitment. The revenue model is structured around individual subscriptions, providing clients with unlimited access to training exercises and additional support features.

The company also emphasizes its commitment to accessibility through a Solidarity Access Program, which offers free access to those in financial difficulty. This tiered pricing strategy is designed to attract a wide range of clients, from individual users seeking self-directed rehabilitation to healthcare professionals looking to integrate Aphasix into their therapy practice. In November 2025, Aphasix SAS raised EUR 1 million in Seed funding from individual investors. The company will use this funding to strengthen technical and research teams, expand product capabilities, and support wider deployment in France and internationally.

Aphasix is actively developing new features for its platform to enhance user experience and is exploring entry into additional European markets by 2026.